Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Syneron Medical, a developer of elos combined-energy medical aesthetic devices, has signed an agreement to acquire San Diego-based laser technology development and research firm, Inlight. Specific terms of the transaction were not disclosed.
Subscribe to our email newsletter
As part of the agreement, Inlight president and co-founder Shlomo Assa will join the Syneron management team. Mr Assa brings deep experience in the laser device industry, previously holding positions at Laser Industries and other companies. In addition, Mr Assa holds multiple US patents for laser-based technology.
Syneron continues to diversify the company’s deep product lineup with the introduction of proprietary products and technology. The Inlight acquisition is the second major product or technology investment for Syneron in 2008. In February 2008, Syneron invested in Rakuto Bio Technologies, an Israeli-based start-up, to develop an advanced whole skin complexion whitening treatment.
Doron Gerstel, CEO of Syneron, said: “This acquisition represents an important expansion of our product development presence in the US and serves as a foundation for our commitment to improve and continue to diversify our product offerings. Utilizing Inlight’s innovative technology, Syneron will develop and release unique and highly competitive skin rejuvenation products, with the first expected to be launched in 2009.”